Literature DB >> 1393399

Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants.

S F Leung1, L Kreel, S Y Tsao.   

Abstract

Computed tomography (CT) scans were performed on a cohort of 60 patients for detection of temporal lobe injury (TLI) at 1-3.5 years after radiation therapy for nasopharyngeal carcinoma. Nine cases of TLI were identified, five of which were asymptomatic. The earliest case of asymptomatic TLI was found at 2.2 years after radiation therapy and the earliest symptomatic case at 2.3 years. A significantly higher incidence of TLI was found in patients with decreased temporal lobe shielding consequent to omitted eyeshield to the anterior photon beam and in patients treated with a hyperfractionation schedule giving 67.2 Gy in 42 fractions in 6 weeks. The incidence in these subgroups at 2-3.5 years after radiation therapy was 56% (5/9 patients) and 35% (8/23 patients), respectively. No patient in this study had TLI in the absence of these two factors. The implications of the results are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1393399     DOI: 10.1259/0007-1285-65-776-710

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  10 in total

Review 1.  Why avoid the hippocampus? A comprehensive review.

Authors:  Vinai Gondi; Wolfgang A Tomé; Minesh P Mehta
Journal:  Radiother Oncol       Date:  2010-10-20       Impact factor: 6.280

Review 2.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

3.  The Influences of Whole Brain Radiotherapy on Social Cognition and Association with Hippocampal and Frontal Dosimetry.

Authors:  Erhan Yuksek; Seda Eroz; Ahmet Yassa; Dilara Akturk; Fagan Zakirov; Funda Engin Akcam; Murat Emul
Journal:  Psychiatr Q       Date:  2015-12

4.  Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  B Khodayari; A L Michaud; S Stanic; O H Wooten; A Dublin; J A Purdy; A M Chen
Journal:  Br J Radiol       Date:  2014-03-13       Impact factor: 3.039

Review 5.  Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.

Authors:  Jing Chen; Meera Dassarath; Zhongyuan Yin; Hongli Liu; Kunyu Yang; Gang Wu
Journal:  Radiat Oncol       Date:  2011-09-30       Impact factor: 3.481

Review 6.  Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management.

Authors:  Xin Zhou; Peiyao Liu; Xiaoshen Wang
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

7.  Hippocampus sparing volumetric modulated arc therapy in patients with loco-regionally advanced oropharyngeal cancer.

Authors:  Seung Won Seol; Brian H Lee; Timothy L Sita; Jay Ram Devineni; Tim J Kruser; Sean Sachdev; Michelle Gentile; Irene Helenowski; Bharat B Mittal
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-24

8.  Bacterial brain abscess in patients with nasopharyngeal carcinoma following radiotherapy: microbiology, clinical features and therapeutic outcomes.

Authors:  Peng-Hsiang Fang; Wei-Che Lin; Nai-Wen Tsai; Wen-Neng Chang; Chi-Ren Huang; Hsueh-Wen Chang; Tai-Lin Huang; Hsin-Ching Lin; Yu-Jun Lin; Ben-Chung Cheng; Ben Yu-Jih Su; Chia-Te Kung; Hung-Chen Wang; Cheng-Hsien Lu
Journal:  BMC Infect Dis       Date:  2012-09-03       Impact factor: 3.090

9.  Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Authors:  Guang Han; Dong Liu; Hua Gan; Kyle A Denniston; Sicong Li; Wenyong Tan; Desheng Hu; Weining Zhen; Zhaohua Wang
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 10.  Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy.

Authors:  Vincent W C Wu; Shing-Yau Tam
Journal:  Radiat Oncol       Date:  2020-05-15       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.